NAD+ Precursors Compared: NR vs NMN for Longevity (UK)

Two precursors, one coenzyme, and a lot of marketing noise.

๐Ÿข Some links in this article are affiliate links. We may earn a small commission if you purchase through them, at no extra cost to you. This does not affect our editorial judgements. See the full disclosure.

TL;DR: NR and NMN both raise NAD+ levels in humans, but the evidence does not clearly favour one over the other. NR has a larger history of manufacturer-funded safety trials; NMN has more rodent longevity data and consumer market presence. For UK buyers, product quality, purity, stable salt form and honest labelling matter far more than the precursor name on the bottle.

๐Ÿข Tortoise Wisdom "The best precursor is the one you can verify, not the one shouted loudest."

1. What Are NR and NMN?

Both compounds are derivatives of vitamin B3 (niacin) and feed into the NAD+ biosynthetic pathway:

  • NR (nicotinamide riboside) is a nucleoside. It is converted inside cells to NMN, then to NAD+.
  • NMN (nicotinamide mononucleotide) is a nucleotide. It is one step closer to NAD+ and requires conversion by the enzyme NMNAT.

For years it was debated whether NMN could be absorbed intact from the gut or whether it had to be converted to NR first. More recent work suggests specific transporters can move NMN into cells in some tissues, but the practical implication for oral supplementation remains unclear.

2. Bioavailability and Pharmacokinetics

Both NR and NMN raise blood NAD+ levels within hours to days. NR has been studied extensively using the NIAGEN ingredient (ChromaDex), with trials showing dose-dependent NAD+ increases and a reasonable safety profile. NMN pharmacokinetic studies have expanded rapidly since 2020, showing that oral NMN at 250โ€“900 mg/day reliably elevates NAD+ metabolites.

Head-to-head human bioavailability studies comparing the same molar dose are limited. Claims that NMN is "more direct" or that NR "does not work" are marketing simplifications, not established scientific conclusions.

3. Clinical Evidence: What Do Human Trials Say?

NR trials

  • Martens et al. (2018): NR at 1,000 mg/day for 6 weeks safely raised NAD+ in older adults.
  • Dellinger et al. (2017): doses up to 2,000 mg/day for 8 weeks were well tolerated.
  • Cardiovascular markers: some trials report improvements in blood pressure and arterial stiffness, though results are mixed.

NMN trials

No human trial has compared NR and NMN for lifespan, and no trial has measured mortality for either compound.

4. Side-by-Side Comparison

Feature NR (Nicotinamide Riboside) NMN (Nicotinamide Mononucleotide)
Molecule type Nucleoside Nucleotide
Pathway step to NAD+ Two steps (NR โ†’ NMN โ†’ NAD+) One step (NMN โ†’ NAD+)
Human safety data volume Larger, especially from NIAGEN trials Growing, mostly Asian + recent Western trials
Longevity mouse data Positive but more mixed Stronger in several studies
Typical consumer dose 300โ€“1,000 mg/day 250โ€“1,000 mg/day
UK availability Widely sold as food supplement Widely sold as food supplement
Price trend Moderate to high Wide range; cheap powders to premium brands

5. Safety Summary

Both NR and NMN are generally well tolerated at the doses used in published trials. Common side effects include mild nausea, flushing, headache and fatigue. Serious adverse events are rare in short-term studies.

Cautions:

  • Long-term safety data beyond 1โ€“2 years are not available.
  • Theoretical concern that raising NAD+ could fuel certain cancers, though no human evidence exists.
  • People with liver or kidney disease, pregnant or breastfeeding women, and those on medication should seek medical advice first.

6. Buying NAD+ Precursors in the UK

  • Purity certificate: look for third-party testing, not just a brand claim.
  • Stable form: NMN-HCl and other salt forms degrade more slowly than free-acid NMN.
  • Clear dose: the label should state the amount of active compound per capsule or serving.
  • UK seller: UK-registered business with a working address and returns policy.
  • No disease claims: avoid any product that claims to treat, cure or reverse ageing. Such claims are unauthorised.

7. References

These sources are referenced inline throughout the article and listed below for full transparency.

Martens et al., 2018 โ€” Nature Communications

"Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults."

View DOI

Trammell et al., 2016 โ€” Nature Communications

"Nicotinamide riboside is uniquely and orally bioavailable in mice and humans." Early pharmacokinetic work on NR.

View DOI

Igarashi et al., 2022 โ€” NPJ Aging and Mechanisms of Disease

"Chronic nicotinamide mononucleotide supplementation elevates blood NAD+ levels and alters muscle function in healthy older men."

View DOI

Yoshino et al., 2021 โ€” Science

"Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women." Important trial for metabolic effects of NMN.

View DOI

Mills et al., 2016 โ€” Cell Metabolism

"Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice." Key NMN mouse longevity study.

View DOI

8. FAQ

What is the difference between NR and NMN?

Both are vitamin B3-derived NAD+ precursors. NR is smaller and can enter some cells directly. NMN is one biochemical step closer to NAD+ and is more widely studied in rodent ageing models. Human head-to-head trials are limited.

Does NR raise NAD+ more than NMN?

Direct human comparisons are scarce. Both reliably raise blood NAD+ levels. Dose, formulation, baseline NAD+ status and individual metabolism likely matter more than the precursor identity.

Is NR safer than NMN?

Both have favourable short-term safety profiles in published trials. NR has been studied in larger and longer manufacturer-funded trials. NMN has more safety data from Asia and smaller Western trials. Long-term safety beyond 1โ€“2 years is not established for either.

Which NAD+ precursor should I buy in the UK?

Choose based on third-party purity testing, stable salt form, clear labelling, a UK-registered seller and realistic expectations. No NAD+ precursor has been proven to extend human lifespan.

9. Affiliate Disclosure

This article may contain affiliate links to supplement products. If you purchase through these links, LongevityTortoise may earn a small commission at no extra cost to you. This does not influence our editorial judgements.

10. Medical Disclaimer

The content on this site is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional before starting any supplement, especially if you are pregnant, nursing, taking medication or have a medical condition.